| |
Population
(CT n = 327, HPV n = 324)
|
Vaccinees
(CT n = 248, HPV n = 245)
|
Non vaccinees
(CT n = 77, HPV n = 77)
|
p-value
|
|---|
|
n
|
pr
|
sd
|
n
|
pr
|
sd
|
n
|
pr
|
sd
|
|---|
|
CT
|
15
|
4.6
|
1.2
|
10
|
4.0
|
1.3
|
5
|
6.5
|
2.8
|
0.360
|
|
HPV global
|
95a
|
29.5
|
2.5
|
70
|
28.6
|
2.9
|
25
|
32.5
|
5.4
|
0.567
|
|
HPV vaccine
|
9b
|
2.8
|
0.9
|
6
|
2.4
|
1.0
|
3
|
3.9
|
2.2
|
0.451
|
- Of 327 samples analysed, 327 were informative for Chlamydia trachomatis (CT) and 324 for Human papillomaviruses (HPV)
- Two subjects were non informative regarding their vaccine status. They were CT and HPV negative. The 15 CT positive cases were found in 13 HPV positive cases and 2 HPV negative cases
- n: number of positive subjects; pr: proportion in %; sd: standard deviation in %; p-value: two-sided Fishers’ p value
- aIn total, 217 subject-genotype combinations were found in the 95 HPV positive subjects. Their distribution is shown in fig. 1
- bFour subjects were infected by a single vaccine genotype. Five were infected by a single vaccine genotype and by at least another non vaccine genotype
